Skip to main content

Adial Pharmaceuticals

Charlottesville, United States

Adial Pharmaceuticals develops prescription medications for addiction and related disorders.

$32.0M raised
Jun 2026
Post-IPO Equity

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Adial Pharmaceuticals

How much funding has Adial Pharmaceuticals raised?
Adial Pharmaceuticals has raised $32.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.
Who are Adial Pharmaceuticals's investors?
Adial Pharmaceuticals's investors include Coastlands Capital, Stonepine Capital Management, Boxer Capital, Keystone Capital Partners, AuGC partners.
Where is Adial Pharmaceuticals headquartered?
Adial Pharmaceuticals is headquartered in Charlottesville, United States.
What does Adial Pharmaceuticals do?
Adial Pharmaceuticals develops prescription medications for addiction and related disorders.
What stage is Adial Pharmaceuticals at?
Adial Pharmaceuticals is at the Post-IPO Equity stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Adial Pharmaceuticals — Funding & Investors." VCBacked, June 11, 2026, https://www.vcbacked.co/company/adial-pharmaceuticals. Accessed July 2, 2026.
APA
VCBacked. (2026). Adial Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/adial-pharmaceuticals
Wikipedia (cite web)
{{cite web |title=Adial Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/adial-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .